These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 33545934

  • 1. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Gupta AK, Maity C.
    Medicine (Baltimore); 2021 Jan 22; 100(3):e23641. PubMed ID: 33545934
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of Bacillus coagulans LBSC in Drug Induced Constipation Associated With Functional Gastrointestinal Disorder: A Double-Blind, Randomized, Interventional, Parallel, Controlled Trial a Clinical Study on Bacillus coagulans LBSC for Drug Induced Constipation Associated With FGIDs.
    Rathi A, Pagare R.
    Glob Adv Integr Med Health; 2024 Jan 22; 13():27536130241286511. PubMed ID: 39295947
    [Abstract] [Full Text] [Related]

  • 3. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
    Maity C, Gupta AK.
    Eur J Clin Pharmacol; 2019 Jan 22; 75(1):21-31. PubMed ID: 30264164
    [Abstract] [Full Text] [Related]

  • 4. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
    Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F, Pande A, Majeed S, Karri SK.
    Nutr J; 2016 Feb 27; 15():21. PubMed ID: 26922379
    [Abstract] [Full Text] [Related]

  • 5. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial.
    Shaikh SS, Kumar S.
    Medicine (Baltimore); 2024 Aug 02; 103(31):e39134. PubMed ID: 39093754
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T.
    Benef Microbes; 2018 Jun 15; 9(4):563-572. PubMed ID: 29695183
    [Abstract] [Full Text] [Related]

  • 7. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome-A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
    Skrzydło-Radomańska B, Prozorow-Król B, Kurzeja-Mirosław A, Cichoż-Lach H, Laskowska K, Majsiak E, Bierła JB, Agnieszka S, Cukrowska B.
    J Clin Med; 2023 Jul 22; 12(14):. PubMed ID: 37510953
    [Abstract] [Full Text] [Related]

  • 8. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Jul 22; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 9. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults.
    Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S.
    Sci Rep; 2019 Aug 21; 9(1):12210. PubMed ID: 31434935
    [Abstract] [Full Text] [Related]

  • 10. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ.
    Methods Find Exp Clin Pharmacol; 2009 Dec 21; 31(10):655-9. PubMed ID: 20140275
    [Abstract] [Full Text] [Related]

  • 11. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
    Hun L.
    Postgrad Med; 2009 Mar 21; 121(2):119-24. PubMed ID: 19332970
    [Abstract] [Full Text] [Related]

  • 12. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Xie P, Luo M, Deng X, Fan J, Xiong L.
    Nutrients; 2023 Sep 04; 15(17):. PubMed ID: 37686889
    [Abstract] [Full Text] [Related]

  • 13. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Abhari K, Saadati S, Hosseini-Oskouiee F, Yari Z, Hosseini H, Sohrab G, Hejazi E, Agah S, Sadeghi A, Hekmatdoost A.
    Eur J Nutr; 2020 Aug 04; 59(5):2111-2117. PubMed ID: 31327047
    [Abstract] [Full Text] [Related]

  • 14. Impact of a Gastrointestinal Stable Probiotic Supplement Bacillus coagulans LBSC on Human Gut Microbiome Modulation.
    Maity C, Gupta PhD AK, Saroj DB, Biyani A, Bagkar P, Kulkarni J, Dixit Y.
    J Diet Suppl; 2021 Aug 04; 18(6):577-596. PubMed ID: 32896190
    [Abstract] [Full Text] [Related]

  • 15. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM, Khosruzzaman SM, Ahmed DS, Sah MP.
    BMC Gastroenterol; 2018 May 25; 18(1):71. PubMed ID: 29801486
    [Abstract] [Full Text] [Related]

  • 16. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
    Srivastava S, Basak U, Naghibi M, Vijayakumar V, Parihar R, Patel J, Jadon PS, Pandit A, Dargad RR, Khanna S, Kumar S, Day R.
    Gut Microbes; 2024 May 25; 16(1):2338322. PubMed ID: 38630015
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T, Zeng H, Long Y, Li X, Sun X, Lan Y, Gao L, Zhang L, Feng Z, Hou X.
    Trials; 2020 Jun 30; 21(1):597. PubMed ID: 32605578
    [Abstract] [Full Text] [Related]

  • 18. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kanarek E, Sowińska A, Cukrowska B.
    Nutrients; 2021 Feb 26; 13(3):. PubMed ID: 33652763
    [Abstract] [Full Text] [Related]

  • 19. The role of Weizmannia (Bacillus) coagulans LMG S-31876 in treating IBS-diarrhea.
    Kallur RK, Madapati S, Mathur A, Bhattacharya S.
    Front Nutr; 2023 Feb 26; 10():1310462. PubMed ID: 38375355
    [Abstract] [Full Text] [Related]

  • 20. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
    Majeed M, Nagabhushanam K, Arumugam S, Majeed S, Ali F.
    Food Nutr Res; 2018 Feb 26; 62():. PubMed ID: 29997457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.